Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuemeng Liu

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Plos One|December 2, 2024
ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in gliomaYibo Wu, Guangjing Mu, Fang Li, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 25, 2025
Preparation and Properties of High-Loading Solvent-Free Dry Electrodes in LiFePO<sub>4</sub> Lithium-Ion BatteriesHang Xie, Xuemeng Liu, Yunlong Cui, et al.
World Neurosurgery|December 15, 2016
Diagnostic Value and Safety of Stereotactic Biopsy in Acquired Immune Deficiency Syndrome Patients with Intracranial Lesions: Systematic Review and Meta-AnalysisJibo Zhang, Xuemeng Liu, Kai Fu, et al.
Clinical and Translational Medicine|January 11, 2023
In-frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistanceWenjiao Zhu, Yuanping Shi, Changrun Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2021
Thiabendazole Inhibits Glioblastoma Cell Proliferation and Invasion Targeting Mini-chromosome Maintenance Protein 2Yaotian Hu, Wenjing Zhou, Zhiyi Xue, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2022
Phenotypic Heterogeneity and Fertility Potential of Patients With 17-Hydroxylase/17,20-lyase DeficiencyYue Xu, Shutian Jiang, Zheng Yan, et al.
Journal of Translational Medicine|February 24, 2023
Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathwayXuemeng Liu, Yaotian Hu, Zhiyi Xue, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 26, 2022
Lessons from 17β-HSD3 deficiency: Clinical spectrum and complex molecular basis in Chinese patientsHui Zhu, Haijun Yao, Xuemeng Liu, et al.
Scientific Reports|January 6, 2025
Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastomaYibo Wu, Fang Li, Chen Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 5, 2022
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 proteinXu Yang, Yan Zhang, Zhiwei Xue, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Plos One|December 2, 2024
ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in gliomaYibo Wu, Guangjing Mu, Fang Li, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 25, 2025
Preparation and Properties of High-Loading Solvent-Free Dry Electrodes in LiFePO<sub>4</sub> Lithium-Ion BatteriesHang Xie, Xuemeng Liu, Yunlong Cui, et al.
World Neurosurgery|December 15, 2016
Diagnostic Value and Safety of Stereotactic Biopsy in Acquired Immune Deficiency Syndrome Patients with Intracranial Lesions: Systematic Review and Meta-AnalysisJibo Zhang, Xuemeng Liu, Kai Fu, et al.
Clinical and Translational Medicine|January 11, 2023
In-frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistanceWenjiao Zhu, Yuanping Shi, Changrun Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2021
Thiabendazole Inhibits Glioblastoma Cell Proliferation and Invasion Targeting Mini-chromosome Maintenance Protein 2Yaotian Hu, Wenjing Zhou, Zhiyi Xue, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2022
Phenotypic Heterogeneity and Fertility Potential of Patients With 17-Hydroxylase/17,20-lyase DeficiencyYue Xu, Shutian Jiang, Zheng Yan, et al.
Journal of Translational Medicine|February 24, 2023
Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathwayXuemeng Liu, Yaotian Hu, Zhiyi Xue, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 26, 2022
Lessons from 17β-HSD3 deficiency: Clinical spectrum and complex molecular basis in Chinese patientsHui Zhu, Haijun Yao, Xuemeng Liu, et al.
Scientific Reports|January 6, 2025
Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastomaYibo Wu, Fang Li, Chen Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 5, 2022
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 proteinXu Yang, Yan Zhang, Zhiwei Xue, et al.
Pageof 6